# Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments

> **NCT06025045** · — · UNKNOWN · sponsor: **Jing Li** · enrollment: 50 (estimated)

## Conditions studied

- Ovarian Cancer Stage IV
- Ovarian Cancer Stage III

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06025045
- **Lead sponsor:** Jing Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06025045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06025045, "Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06025045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*